Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes

David Castel, Cathy Philippe, Raphaël Calmon et al. · Acta Neuropathologica · 2015 · 642 citations · Full text

Hist1h3b K27m Mutations, Pathology, High-grade Gliomas +17

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries

Lindsey M. Hoffman, Sophie E. M. Veldhuijzen van Zanten, Niclas Colditz et al. · Journal of Clinical Oncology · 2018 · 408 citations

Pediatric Brain Tumors, Oncologic Imaging, High-grade Gliomas +23

Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location

Michael Karremann, Gerrit H. Gielen, Marion Hoffmann et al. · Neuro-Oncology · 2017 · 300 citations · Full text

Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria

Marc H.A. Jansen, Sophie E. M. Veldhuijzen van Zanten, Esther Sánchez Aliaga et al. · Neuro-Oncology · 2014 · 220 citations · Full text

Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group

Geert O. Janssens, Lorenza Gandola, Stéphanie Bolle et al. · European Journal of Cancer · 2017 · 151 citations

Survival Benefit, Radiation Therapy, First Progression +9